Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
-
81
-
82
-
83
Results of the LMM analysis for IOP change.
Published 2025“…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …”
-
84
Results of the LMM analysis for GMS change.
Published 2025“…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …”
-
85
-
86
Model selection based on best fit.
Published 2025“…The results showed that malaria incidence decreased with greater variance across Tanzania. Mean malaria incidence decreased from 0.347 (95% CI: 0.336, 0.357) in 2000 to 0.118 (95% CI: 0.114, 0.122) in 2020, relative to the increasing insecticide-treated bednets (ITNs) coverage (0.037; 95% CI: 0.036, 0.039 in 2000 to 0.496; 95% CI: 0.476, 0.517 in 2020). …”
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
Opioid consumption data.
Published 2025“…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
-
95
Prescription data.
Published 2025“…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
-
96
Refill rate by surgical specialty.
Published 2025“…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
-
97
Noncontinuous data on opioid use.
Published 2025“…No significant difference was observed in the mean percentage of prescribed MMEs leftover between the two cohorts (Orthopaedic 47% vs. …”
-
98
Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate...
Published 2025“…Background<p>Multiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. …”
-
99
-
100